Awan, M.J., et al., 2022. DEHART: Dose-Escalated Hypofractionated Adaptive Radiation Therapy with Atezolizumab for Head and Neck Cancers. International Journal of Radiation Oncology, Biology, Physics, 112, p.e23–e24.